Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan
Open Access
- 2 March 2017
- journal article
- research article
- Published by Wiley in Journal of Drug Delivery
- Vol. 2017, 1-10
Abstract
Kanamycin sulphate (KS) is a Mycobacterium tuberculosis protein synthesis inhibitor. Due to its intense hydrophilicity, KS is cleared from the body within 8 h. KS has a very short plasma half-life (2.5 h). KS is used in high concentrations to reach the therapeutic levels in plasma, which results in serious nephrotoxicity/ototoxicity. To overcome aforementioned limitations, the current study aimed to develop KS loaded PLGA-Vitamin-E-TPGS nanoparticles (KS-PLGA-TPGS NPs), to act as an efficient carrier for controlled delivery of KS. To achieve a substantial extension in blood circulation, a combined design, affixation of polyethylene glycol (PEG) to KS-PLGA-TPGS NPs and adsorption of water-soluble chitosan (WSC) (cationic deacetylated chitin) to particle surface, was raised for surface modification of NPs. Surface modified NPs (KS-PEG-WSC NPs) were prepared to provide controlled delivery and circulate in the bloodstream for an extended period of time, thus minimizing dosing frequency. In vivo pharmacokinetics and in vivo biodistribution following intramuscular administration were investigated. NPs surface charge was close to neutral +3.61 mV and significantly affected by the WSC coating. KS-PEG-WSC NPs presented striking prolongation in blood circulation, reduced protein binding, and long drew-out the blood circulation half-life with resultant reduced kidney sequestration vis-à-vis KS-PLGA-TPGS NPs. The studies, therefore, indicate the successful formulation development of KS-PEG-WSC NPs with reduced frequency of dosing of KS indicating low incidence of nephrotoxicity/ototoxicity.Keywords
This publication has 40 references indexed in Scilit:
- Biodistribution of Amikacin Solid Lipid Nanoparticles after Pulmonary DeliveryBioMed Research International, 2013
- Inhalable Antibiotics Manufactured Through Use of Near-Critical or Supercritical FluidsAerosol Science and Technology, 2012
- BDDCS Applied to Over 900 DrugsThe AAPS Journal, 2011
- Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriersJournal of Controlled Release, 2010
- Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer ChemotherapyDiscover Nano, 2010
- Development and characterization of a transdermal patch and an emulgel containing kanamycin intended to be used in the treatment of mycetoma caused byActinomadura maduraeDrug Development and Industrial Pharmacy, 2009
- Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterionJournal of Microencapsulation, 2009
- Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosanBiomaterials, 2009
- Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug deliveryBiomaterials, 2007
- Pharmacokinetics of kanamycin following intramuscular administrationJournal of Pharmacokinetics and Biopharmaceutics, 1973